Feature | Intra-Aortic Balloon Pumps (IABP) | July 24, 2019

Datascope Recalls Intra-Aortic Balloon Pumps Due to Potential Battery Failure

FDA Class I recall includes the Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i IABP 

Datascope Recalls Intra-Aortic Balloon Pumps Due to Potential Battery Failure. FDA Class I recall includes the Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i IABP.

July 24, 2019 — The U.S. Food and Drug Administration announced Maquet/Datascope is recalling all intra-aortic balloon pumps (IABP) due to reports of the batteries failing to hold a charge, stopping unexpectedly and having a shortened run-time. This may cause the device to stop working when being operated by battery only. The FDA issued a recall notice that said if a patient requires life-supporting therapy with an IABP and the device does not work or if therapy is stopped during use due to battery failure, the patient will be at risk of serious injury, including death.

Maquet/Datascope is aware of five patient deaths since March 2016, although the firm has not concluded that the deaths are due solely to the device shutting down while operating on battery power, the FDA said. The company said the recall includes 22,853 devices in the United States.

Last November, the FDA issued a warning letter explaining it was evaluating reports of Getinge's Maquet/Datascope IABP devices shutting down while running on battery power. The company issued a letter to providers warning them about this issue Nov. 1, 2018. The warning has now been elevated to a full recall.

This FDA Class I recall is being conducted to ensure that all IABP users and servicers follow each device's operating instructions manual for recommendations on usage, charging, maintenance and storage of the batteries, as battery run times and discharge cycles vary between IABP models. If battery maintenance is not performed per the operating instructions manual for each IABP, the battery may not provide the expected minimum run time of operating power.

The recall includes the following Maquet/Datascope IABP models. This includes all lot numbers and manufacturing dates:
   • Cardiosave Hybrid IABP
   • Cardiosave Rescue IABP
   • CS300 IABP
   • CS100/100i IABP

The Maquet/Datascope IABPs are cardiac assist devices used with patients undergoing cardiac and non-cardiac surgery, and to treat patients with acute coronary syndrome or complications from heart failure.

Corrective Action to Prevent IABP Battery Failure

On June 17, 2019, Maquet/Datascope sent affected customers an "Urgent Medical Device Correction" notice informing them of the potential risk of battery failure and listing actions that should be taken to minimize patient harm. The vendor is contacting each customer to schedule a training visit to review a recently developed battery operations, care and maintenance reference guide specific to each IABP based on the operating instructions manual(s) provided with each device. The company said no product returns are required.

The notice instructed customers to:

   • Ensure the IABP is plugged into an AC power outlet when the system is not in use and whenever possible during patient use.
   • Refer to the IABP operating instructions manual for recommendations on portable/battery operation when transporting patients within or between facilities.

For the Cardiosave Rescue and Cardiosave Hybrid IABPs only:
   • Have additional charged batteries on hand during transport.
   • Ensure the batteries are properly seated in the battery compartment/charger and the IABP console is completely seated/secured into the IABP cart.
   • For the Cardiosave Hybrid, users can verify if the console is completely seated in the IABP cart by the indicator on the display.
   • Check battery run time and replace batteries as required, as recommended in each IABP's Operating Instructions Manual.

Batteries should be replaced:
   • After reaching the maximum number of charge-discharge cycles.
   • When the battery provides less than the minimum specified run time.
   • If the battery is broken, cracked, leaking or damaged.
   • When the labeled lifetime of the battery is reached.

The company said batteries for the Cardiosave Hybrid and Cardiosave Rescue IABPs sold before June 2015 should be replaced immediately as the labeled lifetime for these batteries is four years. Replacement batteries can be ordered through a sales or service representative. To determine the date of manufacture for all Cardiosave batteries, refer to the document, "Cardiosave Lithium-ion Battery Pack" ML-0795 in the "Urgent Medical Device CorrectionExternal Link Disclaimer" notice.   

For CS100/CS300 systems, informational messages on the display screen provide information to the operator regarding the batteries. The "battery maintenance required" message indicates that the IABP internal battery requires maintenance. The battery test due date or battery replacement date predate the current system date at startup or the internal battery has a total accumulated discharge time in excess of 100 total discharge cycles.

Ensure only Datascope approved or sourced batteries are installed and used for all replacement batteries.

Users can complete and return page 4 of the "Urgent Medical Device Correction Form" by fax to 1-866-340-5660, or email at: [email protected]

Maquet/Datascope is currently developing a Cardiosave battery maintenance software upgrade targeted for early 2020. This updated software requires FDA clearance and once completed, a Maquet/Datascope service representative will contact customers to schedule the installation of the updated software at no cost.

A similar software upgrade was released for the CS300 IABP and CS100 IABP in 2017. If operators are unsure whether their IABP has been updated with the released software upgrade, they can contact Maquet/Datascope Technical Support Department with the model and serial number of the IABP.

Customers with questions about this device correction may contact Maquet/Datascope Technical Support Department at 1-888-627-8383 (select option "3") from 8 a.m. - 6 p.m.(Eastern Time), Monday through Friday.

 

Links to the Getting Resources For Customers:
   • Datascope Urgent Medical Device Correction Notice (June 17, 2019)External Link Disclaimer
   • Datascope Cardiosave, CS100 and CS300 Battery Quick Reference GuidesExternal Link Disclaimer

 

Links to the FDA Class 1 Recall Notices:

Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump

Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump

Class 1 Device Recall CS100 IntraAortic Balloon Pump

Class 1 Device Recall CS300 IntraAortic Balloon Pump

 

Related IABP Content:
Getinge Issues Worldwide Voluntary Correction of Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump
Maquet/Datascope Intra-Aortic Balloon Pumps Might Fail on Battery Power

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...